In observance of Rare Disease Day, it is imperative to underscore the progressive strides within the domain of rare disease research. Rare diseases, characterized by their infrequent occurrence within the general populace, impose significant burdens not only on the affected
Webinars and Events
AARDEX Group is dedicated to staying at the forefront of industry knowledge and expertise. That's why we regularly attend industry events and host webinars featuring top-tier experts in medication adherence. These webinars provide valuable insights and give attendees a front-row seat to the latest industry trends and developments.
LEARN WITH AARDEX GROUP
We are excited to offer on-demand and upcoming webinars focused on medication adherence. Our webinars feature industry-leading experts who provide actionable insights and strategies to improve medication adherence and ultimately, patient outcomes. Whether you are a healthcare provider, researcher, or patient, our webinars offer invaluable information and resources to help you better understand medication adherence and its importance in healthcare. Don't miss out on this opportunity to learn from the best in the field and stay up-to-date on the latest advancements in medication adherence. Register now for our upcoming webinars or access our on-demand webinars at any time.
Mitigating the Risk of Poor Adherence to Injectable Drugs in Hybrid & DCTs
Rebecca Beck, BD, Bernard Vrijens, AARDEX Group, and Arnaud Guillet, Biocorp
The Pill Count Controversy: Why Counting on Accountability is not Enough for Measuring Adherence in Clinical Trials
Job Van Boven, Associate Professor, University Medical Center Groningen, and Bernard Vrijens, Scientific Lead, AARDEX Group
Merck & Biogen: Mitigating the Risk of Poor Adherence in Clinical Trials
Matt Bolton of Merck and Ning Yu of Biogen
Can Modern Medication Adherence Tools Drive Patient Compliance?
Ken Kaitin, TUFTS, John Musaus, Thermo Fisher and Timothy Peters-Strickland, PPD
WHERE TO FIND US NEXT
Our medication adherence experts are on a mission to change the game in clinical trials. They'll be taking our message to the people at several upcoming conferences. If you're ready to join the movement and revolutionize your approach to adherence in clinical trials, be sure to catch us at one of these events.
November 8-11, 2023, Boston, USA
IN CONVERSATION WITH MERCK & BIOGEN
Mitigating the Risk of Poor Adherence in Trials
Watch this live recording with adherence experts from Merck & Biogen to learn about their approach to mitigating the risk of poor adherence in trials.
FROM THE AARDEX GROUP BLOG
Featured Adherence Content
We are thrilled to feature expert insights from Bernard Vrijens, a world-renowned expert on medication adherence. Taking medication as prescribed is crucial to achieving optimal health outcomes, yet non-adherence is a prevalent issue. Bernard Vrijens' extensive research and experience in the field provide invaluable insights into the factors that contribute to medication non-adherence and effective strategies to address them. His contributions to our medication adherence blog offer actionable advice and evidence-based recommendations to improve medication adherence and ultimately, patient outcomes.
It is human nature for people to trust the things that are known to them ahead of the things that are not. Familiarity, after all, brings with it a sense of comfort and reassurance. It is perhaps understandable, therefore, that
In this article, AARDEX Group Quality Manager, Oana Paun, discusses ALCOA+ and its importance for achieving regulatory compliance. For those with a scientific ear, it can be reassuring when you hear ideas discussed in terms of data. The word alone
The list of Neurological conditions is considerable, with epilepsy, Alzheimer’s disease, dementia, stroke, migraine, multiple sclerosis, Parkinson’s disease, neuro infections, and brain tumors, all attributed to this category of disease. Hundreds of millions of people worldwide are affected by neurological
It’s an uncomfortable truth that decision-making is a murky business. While we would all like to think that our actions and the choices underpinning them are rooted in logic, integrity, and reason, the truth is not entirely clear-cut. In reality,
In this article, Dr. Vrijens shares his thoughts on the need for dose optimization in the interests of balancing safety and efficacy. How we use language has a huge bearing on the meaning we convey. Take the word ‘overdose’, for